Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APOBEC3A | P31941 | 1/20 | 0.38 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
| ▸ | CTDSP1 | Q9GZU7 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | HTT | P42858 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.31 |
| ▸ | TDP2 | O95551 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10310392 | 0.89 | ALDH1A1 (0.34) | ALDH1A1 | |
| SCHEMBL4438245 | 0.78 | APOBEC3A (0.39) | APOBEC3AAPOBEC3GCTDSP1KDM4EKMT2A | |
| SCHEMBL10310401 | 0.77 | MAPT (0.35) | APOBEC3AAPOBEC3GKMT2ASMN1; SMN2MAPK1 | |
| SCHEMBL10310410 | 0.69 | PRKDC (0.33) | CYP2C19KDM4EKMT2AHTTSMN1; SMN2 | |
| SCHEMBL4432130 | 0.66 | APOBEC3A (0.40) | APOBEC3AAPOBEC3GCTDSP1KDM4EKMT2A | |
| SCHEMBL29183793 | 0.60 | USP2 (0.47) | KDM4EKMT2ASMN1; SMN2MEN1USP2 | |
| SCHEMBL4809410 | 0.60 | APOBEC3A (0.38) | APOBEC3AAPOBEC3GCTDSP1KDM4EKMT2A | |
| SCHEMBL20321128 | 0.60 | APOBEC3A (0.41) | APOBEC3AAPOBEC3GCYP2C19CTDSP1KDM4E | |
| SCHEMBL4811151 | 0.60 | APOBEC3A (0.48) | APOBEC3AAPOBEC3GCYP2C19CTDSP1KDM4E | |
| SCHEMBL13675276 | 0.59 | KDM4E (0.32) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2805938-A1 | Bi- or tricyclic sterically hindered alkoxyamines and process for their preparation | BASF SE (DE) | 2014-11-26 | — | — | EP | disclosed |
| US-8809533-B2 | Bi- or tricyclic sterically hindered alkoxyamines and process for their preparation | BASF SE (DE) | 2014-08-19 | — | — | US | disclosed |
| US-8809533-B2 | Bi- or tricyclic sterically hindered alkoxyamines and process for their preparation | BASF SE (DE) | 2014-08-19 | — | — | US | disclosed |
| EP-2464628-B1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | BASF SE (DE) | 2014-07-23 | — | — | EP | disclosed |
| US-20140039100-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | BASF SE (DE) | 2014-02-06 | — | — | US | disclosed |
| US-20140039100-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | BASF SE (DE) | 2014-02-06 | — | — | US | disclosed |
| US-20120178829-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | BASF SE (DE) | 2012-07-12 | — | — | US | disclosed |
| US-20120178829-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | BASF SE (DE) | 2012-07-12 | — | — | US | disclosed |
| WO-2011018384-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | BASF SE (DE) | 2011-02-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120178829-A1 | BI - OR TRICYCLIC STERICALLY HINDERED ALKOXYAMINES AND PROCESS FOR THEIR PREPARATION | CAT, SCO2, GPX4 | APOBEC3A 1297/4885APOBEC3G 1362/4885CYP2C19 561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.